Dylan Guiney
Psychiatric/Mental Health · Irvine, CANPI 1295242410
Payments from drug & device makers
Across 1,172 payments — averaging $21.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$3K
- Johnson & Johnson$3K
- Teva Pharmaceuticals USA, Inc.$2K
- Otsuka America Pharmaceutical, Inc.$2K
- Neurocrine Biosciences, Inc.$1K
- plus $11K from 28 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 203 | $3,383 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 133 | $2,955 |
| Johnson & Johnson | 101 | $2,832 |
| Teva Pharmaceuticals USA, Inc. | 112 | $1,778 |
| Otsuka America Pharmaceutical, Inc. | 81 | $1,694 |
| Neurocrine Biosciences, Inc. | 66 | $1,386 |
| Ironshore Pharmaceuticals Inc. | 79 | $1,332 |
| Alkermes, Inc. | 47 | $1,325 |
| Brainsway USA Inc | 2 | $1,107 |
| Vanda Pharmaceuticals Inc. | 41 | $1,086 |
| Lundbeck LLC | 69 | $1,009 |
| Supernus Pharmaceuticals, Inc. | 55 | $937 |
| Sunovion Pharmaceuticals Inc. | 30 | $624 |
| Takeda Pharmaceuticals U.S.A., Inc. | 32 | $475 |
| Axsome Therapeutics, Inc. | 15 | $458 |
| Bausch Health US, LLC | 21 | $430 |
| E.r. Squibb & Sons, L.L.C. | 14 | $388 |
| Indivior Inc. | 13 | $307 |
| Corium, LLC | 11 | $217 |
| Eisai Inc. | 6 | $198 |
| Biogen | 4 | $185 |
| Noven Therapeutics, LLC | 9 | $170 |
| Alpha Cognition USA, Inc. | 2 | $126 |
| Acadia Pharmaceuticals Inc | 1 | $123 |
| Merck | 6 | $91 |
| Neos Therapeutics, LP | 5 | $84 |
| Adlon Therapeutics L.p. | 4 | $82 |
| Vertical Pharmaceuticals, LLC | 4 | $73 |
| Braeburn Inc. | 1 | $23 |
| OWP Pharmaceuticals, Inc. | 1 | $22 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $21 |
| Collegium Pharmaceutical, Inc. | 1 | $20 |
| Boston Scientific | 1 | $20 |
| Idorsia Pharmaceuticals US Inc | 1 | $16 |
How this compares
$24,974 in reported general payments places this provider in the 95th percentile of 2,433 psychiatric/mental health providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other psychiatric/mental health in Irvine
- David OhIrvine$72K
- Phuong TranIrvine$27K
- Jada AlstonIrvine$18K
- Maria AcevedoIrvine$15K
- Salina LumIrvine$15K
- Sylvia GuthrieIrvine$14K
- Farhad NikooIrvine$14K
- Kelly EguchiIrvine$12K
- Michelle NguyenIrvine$11K
- Carey MartinMillbrae$745K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.